K786-3635 Screening compound: 10-(3-chlorobenzyl)-N~8~-(3-morpholinopropyl)-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide

K786-3635 Screening compound: 10-(3-chlorobenzyl)-N~8~-(3-morpholinopropyl)-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide
K786-3635 Screening compound: 10-(3-chlorobenzyl)-N~8~-(3-morpholinopropyl)-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K786-3635
10-(3-chlorobenzyl)-N~8~-(3-morpholinopropyl)-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K786-3635

Molecular Formula

C28H28ClN3O3S (C28 H28 ClN3 O3 S)

Compound Name

10-(3-chlorobenzyl)-N~8~-(3-morpholinopropyl)-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide

IUPAC name

9-[(3-chlorophenyl)methyl]-N-[3-(morpholin-4-yl)propyl]-10-oxo-2-thia-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(15)3(8)461113-hexaene-6-carboxamide

SMILES

O=C(c(cc1)cc(N2Cc3cccc(Cl)c3)c1Sc(cccc1)c1C2=O)NCCCN1CCOCC1

InChI

InChI=1S/C28H28ClN3O3S/c29-22-6-3-5-20(17-22)19-32-24-18-21(27(33)30-11-4-12-31-13-15-35-16-14-31)9-10-26(24)36-25-8-2-1-7-23(25)28(32)34/h1-3,5-10,17-18H,4,11-16,19H2,(H,30,33)

InChI Key

REPBTXGEXRPQIT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15100876

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

522.07

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.695

Distribution Coefficient, logD

4.307

Water Solubility, LogSw

-4.76

Polar Surface Area

51.546

Acid Dissociation Constant (pKa)

15.00

Base Dissociation Constant (pKb)

7.56

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

K786-3635 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Anticancer Library (62698 compounds)

Human Kinases Annotated Library (2415 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Recognition Elements PPI Library (24135 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with K786-3635 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K786-3635?
Check Price and Availability of K786-3635, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K786-3635 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K786-3635
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K786-3635
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K786-3635 available by request